Enveric Biosciences, Inc. Logo

Enveric Biosciences, Inc.

Develops novel small-molecule therapeutics for neuropsychiatric disorders.

ENVB | US

Overview

Corporate Details

ISIN(s):
US02362F3029 (+1 more)
LEI:
Country:
United States of America
Address:
245 FIRST STREET RIVERVIEW II 18TH FLOOR, 2142 CAMBRIDGE

Description

Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company focuses on conditions such as anxiety, depression, and addiction. Leveraging its proprietary discovery and development platform, The Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. Its development pipeline includes candidates such as EB-003 for difficult-to-treat mental health disorders and the EVM301 series.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-12 18:10
8-K
English 393.1 KB
2025-12-11 18:41
8-K
English 72.0 KB
2025-12-10 21:47 English 8.6 KB
2025-12-10 21:47 English 8.8 KB
2025-12-10 02:08
424B3
English 72.2 KB
2025-12-09 06:15 English 5.2 KB
2025-12-06 01:06 English 8.8 KB
2025-12-05 23:40 English 8.9 KB
2025-12-05 23:18
S-3/A
English 102.2 KB
2025-11-14 22:31
10-Q
English 912.7 KB
2025-11-14 22:05
8-K
English 64.2 KB
2025-11-14 22:05
8-K
English 96.7 KB
2025-11-13 21:42 English 9.6 KB
2025-10-27 21:30
DEF 14A
English 1.4 MB
2025-10-23 22:30
8-K
English 112.7 KB

Automate Your Workflow. Get a real-time feed of all Enveric Biosciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Enveric Biosciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Enveric Biosciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.